GoodRx Expands Affordable Access to Cholesterol Drug Repatha

MT Newswires Live
昨天

GoodRx (GDRX) said Monday it is expanding the availability of Amgen's (AMGN) cholesterol drug Repatha at a lower price.

Starting Monday, patients will be able to use GoodRx to buy Repatha for $239 at over 70,000 pharmacies in the US, GoodRx said, adding that the price represents a savings of about 60% off the retail pharmacy list price.

GoodRx shares were up 3.5% in early trading, while Amgen was down 0.5%.

Price: 4.69, Change: +0.16, Percent Change: +3.53

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10